# TORIGEN PHARMACEUTICALS, INC.: Form D filings

TORIGEN PHARMACEUTICALS, INC., a pharmaceuticals company in Farmington, CT, filed 5 Form D notices with the SEC between 2019 and 2022. The latest, on May 24, 2022, reports $4.6 million sold of a $10 million offering to 30 investors.

Find out what TORIGEN PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20TORIGEN%20PHARMACEUTICALS%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=TORIGEN%20PHARMACEUTICALS%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Ftorigen-pharmaceuticals-inc-1764961)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20TORIGEN%20PHARMACEUTICALS%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=TORIGEN%20PHARMACEUTICALS%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Ftorigen-pharmaceuticals-inc-1764961)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut): 428 rows, by operating companies, filed since November 1, 2024, $21.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/connecticut
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 400 FARMINGTON AVE., R1855 CB129, Farmington, CT, 06032
- Phone: (860) 519-9956
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1764961

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 24, 2022 | New notice | $10,000,000 | $4,601,438 | $5,398,562 | 30 | May 9, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1764961/000176496122000001/0001764961-22-000001-index.htm) |
| Dec 6, 2021 | New notice | $1,500,000 | $1,223,912 | $276,088 | 16 | Nov 22, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1764961/000176496121000002/0001764961-21-000002-index.htm) |
| Mar 5, 2021 | Amendment | $3,500,000 | $3,272,000 | $228,000 | 38 | Jun 2, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1764961/000176496121000001/0001764961-21-000001-index.htm) |
| Jun 16, 2020 | New notice | $1,500,000 | $613,000 | $887,000 | 10 | Jun 2, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1764961/000176496120000001/0001764961-20-000001-index.htm) |
| Jan 16, 2019 | New notice | $2,000,000 | $1,760,000 | $240,000 | 9 | Jan 4, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1764961/000176496119000001/0001764961-19-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Blake Hawley | Director |  |
| Kevin Crowley | Director |  |
| John Kallassy | Executive Officer |  |
| Musan Duric | Director |  |
| Ashley Kalinauskas | Executive Officer, Director |  |
| Elizabeth Galbut | Director |  |

## Other pharmaceuticals companies in Connecticut that filed recently

- [Thetis Pharmaceuticals LLC](https://specstream.ai/data/form-d/company/thetis-pharmaceuticals-llc-1528491) $560,300 · Oct 13, 2026
- [Inventure, LLC](https://specstream.ai/data/form-d/company/inventure-llc-1706556) $82,345 · Sep 3, 2026

[Every Form D from the week of May 23, 2022](https://specstream.ai/data/form-d/week/2022-05-23) · [All recent filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what TORIGEN PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).